외음질 칸디다증에서 Candida albicans의 Azole 감수성
Susceptibilities to Azoles of Candida albicans in Vulvovaginal Candidiasis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: There are limited data regarding the antifungal susceptibility of Candida albicans causing recurrent vulvovaginal candidiasis. Objective: The aim of the present study was to evaluate the effect of azoles susceptibilities on treatment failure and recurrence of vulvovaginal candidiasis. Methods: Species identification was performed on 84 vaginal Candida isolates collected from October 2008 to June 2010 from 404 patients with suspected vulvovaginitis. MICs of C. albicans (26isolates) to fluconazole, itraconazole, and voriconazole were tested by broth microdilution method of the Clinical and Laboratory Standards Institute (CLSI) M27-A2. Results: C. albicans was the most frequently isolated (88.1%). All isolates were susceptible to fluconazole, itraconazole, and voriconazole. Trailing growth was found in treatment success group (10.0%) and treatment failure group (33.3%). Conclusions: The results of this study suggest the possibility that trailing growth have influence on treatment failure of vulvovaginal candidiasis.
Abstract
Background: There are limited data regarding the antifungal susceptibility of Candida albicans causing recurrent vulvovaginal candidiasis. Objective: The aim of the present study was to evaluate the effect of azoles susceptibilities on treatment failure and recurrence of vulvovaginal candidiasis. Methods: Species identification was performed on 84 vaginal Candida isolates collected from October 2008 to June 2010 from 404 patients with suspected vulvovaginitis. MICs of C. albicans (26isolates) to fluconazole, itraconazole, and voriconazole were tested by broth microdilution method of the Clinical and Laboratory Standards Institute (CLSI) M27-A2. Results: C. albicans was the most frequently isolated (88.1%). All isolates were susceptible to fluconazole, itraconazole, and voriconazole. Trailing growth was found in treatment success group (10.0%) and treatment failure group (33.3%). Conclusions: The results of this study suggest the possibility that trailing growth have influence on treatment failure of vulvovaginal candidiasis.
참고문헌 (22)
- Sobel JD, "Vaginitis", N Engl J Med, 337, pp.1896~1903 (1997)
- Sobel JD, "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations", Am J Obstet Gynecol, 178, pp.203~211 (1998)
- Nikitin MV, "Study of Candida albicans strains isolated from women with various forms of vaginal candidiasis", Bull Exp Biol Med, 135, pp.276~280 (2003)
- Sobel JD, "Vulvovaginal candidiasis", Lancet, 369, pp.1961~1971 (2007)
- Vazquez JA, "Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis", J Infect Dis, 170, pp.566~1569 (1994)
- Sobel JD, "Pathogenesis and epidemiology of vulvovaginal candidiasis", Ann N Y Acad Sci, 544, pp.547~557 (1988)
- Wayne, PA, "Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved Standard", ~ (2002)
- Vermitsky JP, "Survey of vaginalflora Candida species isolates from women of different age groups by use of species-specific PCR detection", J Clin Microbiol, 46, pp.1501~1503 (2008)
- Corsello S, "An epidemiological survey of vulvovaginal candidiasis in Italy", Eur J Obstet Gynecol Reprod Biol, 110, pp.66~72 (2003)
- Holland J, "Vulvovaginal carriage of yeasts other than Candida albicans", Sex Transm Infect, 79, pp.249~250 (2003)
- Fan SR, "Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006", J Obstet Gynaecol Res, 34, pp.561~566 (2008)
- Mohanty S, "JE. Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis", Indian J Med Res, 126, pp.216~219 (2007)
- Cetin M, "Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods", Scand J Infect Dis, 39, pp.584~588 (2007)
- Okungbowa FI, "The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian cities", Rev Iberoam Micol, 20, pp.60~63 (2003)
- Kim JH, "A clinical evaluation of fluconazole as a single dose treatment for vaginal infections with Candida", Korean J Obstet Gynecol, 35, pp.1309~1316 (1992)
- Shin JH, "Distribution and antifungal susceptibility of Candida species isolated from clinical specimens during the past six years", Korean J Clin Microbiol, 7, pp.164~170 (2004)
- Richter SS, "Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases", J Clin Microbiol, 43, pp.2155~2162 (2005)
- Lockhart SR, "Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2", J Clin Microbiol, 34, pp.767~777 (1996)
- 이미경, "Species Distribution and Antifungal Susceptibilities of Yeast Clinical Isolates from Three Hospitals in Korea, 2001 to 2007", Annals of Laboratory Medicine, 30(4), pp.364~372 (2010), 대한진단검사의학회
- Shahid Z, "Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of longterm fluconazole therapy", Diagn Microbiol Infect Dis, 64, pp.354~356 (2009)
- Arthington-Skaggs BA, "Frade JP, Brandt ME, Hajjeh RA, et al. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates", Antimicrob Agents Chemother, 46, pp.2477~2481 (2002)
- Lee MK, "Arthington- Skaggs BA. Drug resistance genes and trailing growth in Candida albicans isolates", J Antimicrob Chemother, 53, pp.217~224 (2004)